Long-term kidney outcomes of semaglutide in obesity and cardiovascular disease in the SELECT trial - Nature.com

[unable to retrieve full-text content]

Long-term kidney outcomes of semaglutide in obesity and cardiovascular disease in the SELECT trial  Nature.com